Tags |
|
|
Links |
|
|
Advice You - Family-Owned Businesses and Succession, A Guide To A Smooth Transition
Upon reading of the death of Peter Drucker, I was reminded of the problems of family business, individual accountabi
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
lity, and succession of which he wrote years ago.
In the over 30 years that I have worked with family owned busines
In the over 30 years that I have worked with family owned busines
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
es there have been so many occasions where the business is on the brink of failure, will fail, or has substandard pe
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
formance because the company has not been prepared for “up and comers” from the family within the enterprise.
All t
All t
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
o often family business “up and comers” are unprepared with a lack of financial management or operational managemen
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
training and preparation. They are also unprepared to make capital investments in equipment, plant, marketing, or k
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
y personnel because these have been ignored for years in favor of stripping the company of resources and cash in or
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
er to "turn a profit".
Often times, even if these problems have not taken place, some or all of these “up and comer
Often times, even if these problems have not taken place, some or all of these “up and comer
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
successors, will never make it in the business. Instead, their lack of skills, absence of capacity to manage and le
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
d, and lack of earned respect from critical non-family employees dooms the enterprise to mediocrity or failure.
One
One
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
of the best investments family ownership can make is to contract with experienced, performance-oriented resources to
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
solve these problems. These resources, contractors, consultants, create implementable programs of business training
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
in the financial management of that particular business, in operations, and sales management.
Using these types of
Using these types of
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
esources, up-and-comers can learn operational roles, earn the respect of employees, all while getting an MBA in thei
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
own business.
If these family "up-and-comers" can’t or won’t perform, or won't agree to sharpen their skills... th
If these family "up-and-comers" can’t or won’t perform, or won't agree to sharpen their skills... th
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
n pay them if you must, but let them stay home.
Critical operational roles should never be an entitlement o
Critical operational roles should never be an entitlement o
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
inheritance!
The business can’t succeed unless critical ownership and management can demonstrate their ab
The business can’t succeed unless critical ownership and management can demonstrate their ab
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
lity to perform to norms that are at a minimum required for profit, growth, and value building. You need to clearly
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
utline what other critical employees can expect of that family manager... thus respect, leadership, non-family emplo
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ee accountability, and the opportunity to maximize planned profit and revenue growth become practical and achievable
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.adviceyou.org.ua/article/20372/adviceyou-FamilyOwned-Businesses-and-Succession-A-Guide-To-A-Smooth-Transition.html">Family-Owned Businesses and Succession, A Guide To A Smooth Transition</a>
BB link (for phorums):
[url=http://www.adviceyou.org.ua/article/20372/adviceyou-FamilyOwned-Businesses-and-Succession-A-Guide-To-A-Smooth-Transition.html]Family-Owned Businesses and Succession, A Guide To A Smooth Transition[/url]
Related Articles:
Standardize Your Processes to Produce Best Results
How To Get a Job Offer From Every Interview
Bookmark it:
|